Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services
JAMA Network Open 10.1001/jamanetworkopen.2026.30608August 19, 2026 at 11:00 AM EDT
In this multisite cohort of participants receiving state-regulated psilocybin services in Oregon, serious adverse reactions were uncommon. Most participants reported improvements in mental health, wellness, and life satisfaction. Longitudinal findings support safety and potential benefits that can inform clinicians, policymakers, and the public as other state-regulated psychedelic services emerge.
Meeting Information
This paper is being presented at the Oregon Psychedelic Innovation Summit.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.